Nanocarriers with multi-photon response elements

US9724417B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9724417-B2
Application numberUS-201414455613-A
CountryUS
Kind codeB2
Filing dateAug 8, 2014
Priority dateSep 23, 2009
Publication dateAug 8, 2017
Grant dateAug 8, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions are provided in which dendrimers and/or nanoparticles are synthesized with multi-photon responsive elements and self-immolative oligomers. The compositions may be utilized to selectively deliver Payloads within tissue by irradiating the compositions. The compositions may also be used to amplify sensitivity to irradiation.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for delivering a Payload to a tissue comprising the steps of: synthesizing a particle comprising polymer strands and a crosslinker to form a molecular network that encapsulates the Payload, wherein said crosslinker comprises a multi-photon responsive element covalently linked to a self-immolative backbone subunit comprising the structure where “PG” denotes a protecting group; administering said particle to said tissue; and irradiating said tissue comprising said particle with electromagnetic radiation; wherein said particle is disrupted in situ following absorption of said electromagnetic radiation. 2. The method of claim 1 , wherein said electromagnetic radiation is near infrared red light or ultraviolet light. 3. The method of claim 1 , wherein said method provides an amplified response to said electromagnetic radiation. 4. The method of claim 1 , wherein said Payload comprises a pharmaceutical agent, stem cell differentiation agents, immunogens or antibodies. 5. The method of claim 1 , wherein said multi-photon responsive element is a two-photon responsive element. 6. The method of claim 1 , wherein said multi-photon responsive unit is a bromo-coumarin group. 7. The method of claim 1 , wherein said molecular network comprises acrylamide polymers. 8. The method of claim 1 , wherein said molecular network comprises PEG polymers. 9. The method of claim 1 , wherein said self-immolative backbone subunit is a self-immolative dendrimer oligomer. 10. The method of claim 1 , wherein said multi-photon responsive unit comprises the structure 11. A method for delivering a Payload to a target tissue comprising: encapsulating the Payload within a plurality of nanocarriers, each nanocarrier comprising a molecular cage synthesized by cross-linking polymer strands with a multi-photon responsive element covalently linked to a self-immolative backbone subunit comprising the structure where “PG” denotes a protecting group; administering said plurality of nanocarriers to said target tissue; and irradiating said target tissue and the plurality of nanocarriers with electromagnetic radiation; wherein said molecular cage unravels and releases the Payload in situ following absorption of said electromagnetic radiation. 12. The method of claim 11 , wherein said electromagnetic radiation is near infrared red light or ultraviolet light. 13. The method of claim 11 , wherein said Payload comprises a pharmaceutical agent, stem cell differentiation agents, immunogens or antibodies. 14. The method of claim 11 , wherein said multi-photon responsive element is a two-photon responsive element. 15. The method of claim 11 , wherein said polymer strands comprise polyacrylamide polymers. 16. A method for delivering a Payload to a target tissue comprising: encapsulating the Payload within a molecular network comprising strands of polymer crosslinked by a crosslinker to form a carrier that mechanically encapsulates the Payload, the crosslinker comprising a dual-photon responsive element covalently linked to a self-immolative backbone subunit comprising the structure where “PG” denotes a protecting group; administering a plurality of said carriers to said target tissue; and irradiating said target tissue and said carriers with a dual-photon trigger; wherein, upon exposure to the dual-photon trigger, the crosslinker cleaves to unravel the strands and release the Payload in situ. 17. The method of claim 16 , wherein said electromagnetic radiation is near infrared red light or ultraviolet light. 18. The method of claim 16 , wherein said Payload comprises a pharmaceutical agent, stem cell differentiation agents, immunogens or antibodies.

Assignees

Inventors

Classifications

  • DNA (RNA) vaccination · CPC title

  • derived from hydroxycarboxylic acids · CPC title

  • non-covalent binding · CPC title

  • obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates · CPC title

  • Inorganic adjuvants · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9724417B2 cover?
Compositions are provided in which dendrimers and/or nanoparticles are synthesized with multi-photon responsive elements and self-immolative oligomers. The compositions may be utilized to selectively deliver Payloads within tissue by irradiating the compositions. The compositions may also be used to amplify sensitivity to irradiation.
Who is the assignee on this patent?
Univ California
What technology area does this patent fall under?
Primary CPC classification A61K41/008. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).